Enteric Glial Cell Culture to Mimic In Vivo Obesity and Neurodegenerative Disorders
2026 •
Original Research •
10.1007/978-1-0716-4795-0_9
SodiuM glucose cotrANsporter-2 (SGLT-2) inhibitors in the treatment of type II DiAbetes in Tuscany: utiLizatiOn patteRns, and related clinical use evaluation; the MANDALORE study protocol
2026 •
Original Research •
10.3389/fendo.2026.1741084
Mechanistic Rationale of Seladelpar’s Clinical Efficacy through the Selective PPAR-δ Activation in Primary Biliary Cholangitis
2026 •
Original Research •
10.1016/j.phrs.2026.108144
Early Increase of Plasma Soluble VEGFR-2 Is Associated with Clinical Benefit from Second-Line Treatment of Paclitaxel and Ramucirumab in Advanced Gastric Cancer
2022 •
Original Research •
Synergistic Activity of Linifanib and Irinotecan Increases the Survival of Mice Bearing Orthotopically Implanted Human Anaplastic Thyroid Cancer
2020 •
Original Research •
Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats
2017 •
Original Research •
10.1053/j.gastro.2017.06.004
Akt1 Rs2498801 Is Related to Survival in Head and Neck Squamous Cell Cancer Treated with Radiotherapy
2015 •
Original Research •
A New Biometric Tool for Three-Dimensional Subcutaneous Tumor Scanning in Mice
2014 •
Original Research •
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction
2013 •
Original Research •
10.1161/hypertensionaha.113.01961
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation
2013 •
Original Research •
10.1161/HYPERTENSIONAHA.111.00995
Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats
2009 •
Original Research •
10.1210/en.2008-1112
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon
2006 •
Original Research •
10.1111/j.1365-2982.2006.00795.x
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds
2004 •
Original Research •
10.1016/j.taap.2003.10.006
A Naturally Occurring Soluble Form of Vascular Endothelial Growth Factor Receptor 2 Detected in Mouse and Human Plasma
2004 •
Original Research •
Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis
2003 •
Original Research •
10.1038/sj.bjp.0705249
Improved tonsillar disposition of azithromycin following a 3-day oral treatment with 20 mg kg(-1) in paediatric patients
2002 •
Original Research •
10.1016/s1043-6618(02)00042-7
Protracted Low-Dose Effects on Human Endothelial Cell Proliferation and Survival in Vitro Reveal a Selective Antiangiogenic Window for Various Chemotherapeutic Drugs
2002 •
Original Research •
Antitumor Effects in Mice of Low-Dose (Metronomic) Cyclophosphamide Administered Continuously through the Drinking Water
2002 •
Original Research •
Comparative Pharmacokinetic Analysis of 5-Fluorouracil and Its Major Metabolite 5-Fluoro-5,6-Dihydrouracil after Conventional and Reduced Test Dose in Cancer Patients
2000 •
Original Research •
Inhibition of Experimental Angiogenesis by the Somatostatin Analogue Octreotide Acetate (SMS 201-995)
1997 •
Original Research •
Plasma and Tissue Disposition of Paclitaxel (Taxol) after Intraperitoneal Administration in Mice
1995 •
Original Research •